Access Vascular
MA - BillericaBiotechnology
Focus: Access Vascular is a private biotechnology company developing hydrogel-based venous access devices, currently operating at early stage with a team of 1-50 employees in Billerica, MA. The company focuses on improving catheter performance through proprietary hydrophilic biomaterial technology.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
1-50
Open Jobs
5
Should You Work at Access Vascular?
AI assessmentBest suited for early-career engineers or scientists willing to accept pre-clinical risk in exchange for hands-on device development experience.
Why Work Here
- Early-stage medical device innovation in a high-need clinical area (venous access) with multiple product candidates in early development.
- Lean team structure (1-50 employees) offers direct impact and broad exposure across R&D, QA, and supply chain functions.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Hydrophilic Biomaterial Catheter
Midline CatheterHydrophilic Biomaterial PICC
Peripheral ICCHydroPICC
Help build intelligence for Access Vascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.